Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
4
×
boston blog main
life sciences
national blog main
startups
venture capital
biotech
clinical trials
deals
ipo
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew berens
anirvan ghosh
armo biosciences
astrazeneca
autoimmune
avalon ventures
avapritinib
bio
biogen
blueprint medicines
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
cerovene
coi pharmaceuticals
correlation ventures
covid-19
What
plans
4
×
announced
cancer
company
ipo
raise
acquisitions
advance
amazon
approval
bezos
billion
bio
biology
blueprint
ceo
chasing
collabs
come
covid
cytokine
daniel
deadly
deal
deciphera
doesn’t
drug
drugs
early
enhanced
fda
files
filing
financing
forms
founder
fund
funding
gates
gi
Language
unset
Current search:
plans
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@techcrunch.com
7 years ago
Grail is raising at least $1 billion to fund its early cancer screening test
